Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma

Detalles Bibliográficos
Autores principales: Zhang, Zhihui, Zhang, Chaoqi, Zhang, Guochao, Luo, Yuejun, Xue, Liyan, Zeng, Qingpeng, Wu, Peng, Wang, Lide, Sun, Nan, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236121/
https://www.ncbi.nlm.nih.gov/pubmed/34185404
http://dx.doi.org/10.1002/ctm2.456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236121/
https://www.ncbi.nlm.nih.gov/pubmed/34185404
http://dx.doi.org/10.1002/ctm2.456

Ejemplares similares